AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

OptimizeRx Corp Director's Dealing 2024

Aug 5, 2024

33090_dirs_2024-08-05_162fedd5-0cd3-4227-819b-2887b9bdde6a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2024-08-02

Reporting Person: McCarthy Brian Clark (Chief Revenue Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct